Crown Reserve Acquisition Corp. I (CRACU US) is a Cayman Islands-domiciled blank check company, also known as a SPAC, focused on acquiring or merging with targets in the pharmaceutical, medical technology, medical equipment, and healthcare IT industries. Founded in 2025, it is led by Chairman and CEO Prashant Patel, a registered pharmacist with experience in pharmacies, pharmaceutical reverse distribution, and SPAC advising, alongside CFO Eric Sherb, an accountant managing EMS Consulting Services.

The company plans to list on Nasdaq on November 7, 2025, offering 15 million units at $10.00 each to raise $150 million (USD). Each unit includes one Class A ordinary share, one-half of one redeemable warrant (exercisable at $11.50 per share), and one right to receive one-fifth of one Class A ordinary share upon a business combination. An underwriter option allows for up to 2.25 million additional units. The offering is managed by Polaris Advisory Partners, a Kingswood division, with Thunder Rock Capital as an advisor. Proceeds will be deposited into a trust account at $10.00 per unit for the initial business combination. Post-separation, shares, warrants, and rights will trade as CRAC, CRACW, and CRACR, respectively, with closing expected November 10, 2025, subject to conditions.